{
    "clinical_study": {
        "@rank": "136112", 
        "acronym": "ECAD-HF", 
        "arm_group": [
            {
                "arm_group_label": "intensive disease management", 
                "arm_group_type": "Experimental", 
                "description": "Planned consultations with HF specialist including biological test at weeks 1, 2 and 4; in addition to usual care."
            }, 
            {
                "arm_group_label": "usual disease management", 
                "arm_group_type": "Active Comparator", 
                "description": "usual care according to guidelines; including first medical consultation and biological test within the 4-week time following discharge."
            }
        ], 
        "brief_summary": {
            "textblock": "After decompensated heart failure, a number of patients have high risk of early\n      rehospitalization as well as death. Specialized medical management for a short period but\n      very early after discharge could be critical for optimizing care and improving early\n      outcome.\n\n      This study aims to compare such early intensive medical management with usual care in\n      high-risk patients after discharge."
        }, 
        "brief_title": "Early Care After Discharge of HF Patients", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "detailed_description": {
            "textblock": "At discharge, high-risk HF patients are selected and randomized in two groups:\n\n        -  Control group: usual disease management according to guidelines and including first\n           medical consultation and biological test within the 4-week time following discharge.\n\n        -  Active group: consultations with HF specialist including biological test at weeks 1, 2\n           and 4 are planned in addition to usual management."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years or more\n\n          -  consent signed\n\n          -  Acute heart failure with one or more of following criteria at discharge:\n\n          -  BNP > 350 pg/ml or NTproBNP > 2200 pg/ml\n\n          -  Serum creatinine \u2265 180\u00b5M\n\n          -  Systolic blood pressure \u2264 110mmHg\n\n          -  HF-related unplanned hospitalizations within 6 previous months.\n\n        Exclusion Criteria:\n\n          -  acute coronary syndrome,\n\n          -  acute myocarditis,\n\n          -  isolated right HF,\n\n          -  transient HF,\n\n          -  planned cardiac surgery,\n\n          -  high risk of short-term non-cardiac death,\n\n          -  planned management within rehabilitation center/HF clinic at discharge"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "534", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820780", 
            "org_study_id": "P110128"
        }, 
        "intervention": [
            {
                "arm_group_label": "intensive disease management", 
                "intervention_name": "Natriuretic peptides levels to J7 and J14", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "intensive disease management", 
                "description": "Optimization of treatments Education on the signs of alert of the disease and on the medicines Reduction of the rate of BNP or NTproBNP = 30 % between the exit of the hospitalization and the second consultation Planning of an adapted coverage", 
                "intervention_name": "Consultations specialized to J7 and J14", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "intensive disease management", 
                    "usual disease management"
                ], 
                "intervention_name": "Phone calls in 6 months and 12 months", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "intensive disease management", 
                    "usual disease management"
                ], 
                "intervention_name": "Natriuretic peptides levels at 6 months", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "intensive disease management", 
                    "usual disease management"
                ], 
                "intervention_name": "Consultation with the general doctor or the cardiologist to J30 with blood results", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Heart failure", 
            "Disease management program"
        ], 
        "lastchanged_date": "April 11, 2014", 
        "location": {
            "contact": {
                "email": "damien.logeart@lrb.aphp.fr", 
                "last_name": "Damien LOGEART, MD, PhD", 
                "phone": "+33149958674"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75010"
                }, 
                "name": "Service de Cardiologie - Hopital Lariboisi\u00e8re"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Usefulness of a Short-time But Very Early Specialized Follow-up After Hospitalization for Acute Heart Failure: a Randomized Controlled Trial.", 
        "overall_contact": {
            "email": "damien.logeart@lrb.aphp.fr", 
            "last_name": "LOGEART Damien, MD, PhD", 
            "phone": "+33149958674"
        }, 
        "overall_official": {
            "affiliation": "Lariboisiere Hospital, APHP", 
            "last_name": "LOGEART Damien, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of participants with all cause death or unplanned hospitalization at 6 months", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820780"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "All cause mortality at 12 months", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "Unplanned HF-related hospitalization at 6 and 12 months", 
                "safety_issue": "No", 
                "time_frame": "6 and 12 months"
            }, 
            {
                "measure": "Number of alive and hospitalization-free days at 6 and 12 months", 
                "safety_issue": "No", 
                "time_frame": "6 and 12 months"
            }, 
            {
                "measure": "Mean and distribution modified Goldman classe at 6 months", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Natriuretic peptides blood levels at 6 months.", 
                "safety_issue": "No", 
                "time_frame": "6 months."
            }, 
            {
                "measure": "Global cost of patient management", 
                "safety_issue": "No", 
                "time_frame": "from day0 to 12 months"
            }, 
            {
                "measure": "HF-treatment at 6 months", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Mean and distribution NYHA classe at 6 months", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}